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2The unified theory of dose and effect, as indicated by the median-effect equation for single and multiple 
entities and for the first and higher order kinetic/dynamic, has been established by T.C. Chou and it is 
based on the physical/chemical principle of the mass-action law (J. Theor. Biol. 59: 253-276, 1976; 
Pharmacological Rev. 58: 621-681, 2006). Rearrangements of the median-effect equation lead to 
Michaelis-Menten, Hill, Scatchard, and Henderson-Hasselbalch equations. The “median” serves as the 
“universal reference point” and the “common link” for the relationship of all entities at all dynamic 
orders, and is also the “harmonic mean” of kinetic dissociation constants. Over 300 mechanism-specific 
equations have been derived and published using the mathematical induction-deduction process. These 
equations can be deduced into several general equations, including the median-mediated whole/part 
equation, combination index theorem, isobologram equation, and polygonogram. It is proven that “dose”
and “effect” are interchangeable, thus, “substance” and “function” are interchangeable, which leads to 
“the-unity theory” in philosophical context. Based on the mass-action law, the fundamental conceptual 
claim is that “one can draw a specific cure for only two data points”, if they are determined accurately. 
Furthermore, instead of drawing an empirical curve for data-fitting, we can now use the data points to fit 
the median-effect principle of the mass-action law by automated computer simulation. This small kill 
has far reaching consequences in biomedical sciences including small size experimentation, efficient 
experimental design and data interpretation, efficiency in drug discoveries, quantifying/simulating 
synergism in drug combinations, assessing low-dose risk of carcinogens, toxic substances or radiation, 
and conserving laboratory animals’ lives. For the “combination index” alone, the theory has been cited 
in over 345 different biomedical journals, based on the Thompson-ISI Web search, indicating broad 
applications.
The Mass-Action-Law Based GPS Concept 
for Bio-Informatics 
Summary
by T.C. Chou
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3The General System Biology
• Based on the Physico-Chemical Principle of the Mass-Action law
• “Median” as the Universal “Common Link” and “Reference Point” (GPS)
• Approach of Efficient Pharmacodynamics
(Chou, T.C. Pharmacol. Rev. 58: 621-681, 2006)
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4DISCOVERY OF THERAPIES
• Single Drug
— Single Entity or Modality
Practical and Efficient Approach
Median-Effect Principle of the Mass Action Law
•Drug Combination
— Multiple Drugs or Modalities
> 20 different definitions for synergy in bio-medical literature
Confusions in Synergy Claims lasted over 100 Years
Combination Index for Synergy Definition Based on the Mass-Action Law
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5Changing Climates in Cancer Research
Therapy Approaches
Pharmacology                Virology           Immunology       Molecular                   Cell                   Post-genome 
(Chemotherapy)         (Transfection                 (MAb)       Biology                   Biology era
Viral Carcinogenesis)               (Cloning               (Gene/function) 
PCR                          (IT)
Gene therapy)Arbitrary 
Hot Index
1950           1960         1970           1980 1990 2000 2010
Surgery & Radiation
Prevention
Does Anyone Know Where to Go?
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6System Biology? How to Integrate These?
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7Myth of Semantics
What Do You Mean by “Mechanism”?
Quantum Mechanical, Chemical, Molecular,
Cellular, Pharmacological, Animal,
Clinical, Epidemiological?
Do we really understand mechanism of Aspirin?
What Do You Mean by “Target”?
Isn’t It Just Receptor?
What Do You Mean by “Pathway”?
An Enzyme Reaction is a Mini-Pathway.
We Need to Understand the Kinetics/Dynamics/Mathematics
of Simple Ones First
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Basic, Fundamental Issues in Bio-Medical 
Research
1. How to Draw a Dose-Effect Curve?
[Can we draw a curve from only two data points? Yes!!]
2. What is the “Additive Effect” of Two Drugs?
[What is synergy?]
3. System Biology?
[How to integrate them?]
4. Are We on the Right Track?
[Or medical research lopsided?]
5. Is There A Unified Theory?
[Yes. There is a unified “common link” and “reference point”!]
6. What are the Roots of Skyrocketing Costs for
Medical Care and Medical Research?
[Yes. There are  ways to constrain or to conserve!]
— Questions raised after spending hundred billions of dollars
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A Practical R & D Proposal
• To Remain Efficient and Competitive, It is Essential to  
Separate “Basic Research” from “Drug Discovery”
• To be Economical, Let Academia to Do Basic 
Research for “Knowledge” and Let Big Pharma focus 
on “Efficacy and Safety” for New Products or Pipe Line.
• Using the Unified Theory of Mass-Action Law to Conduct 
Small-Size Experimentation and Computerized Simulation 
to Constrain the Costs and to Conserve Animals
T.C. Chou (a personal view)
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“Approach” Leads to “Results” in Drug Discovery
• Based on U.S. Patent and Trademark Office 
Record, Researchers with 17 or More Patents 
since 1976 constitute 99th Percentile of Inventors.
• Chou, T.C. with Small Number of Staff and 
Limited Resources now has 25 U.S. Patents, 
since 1991.
• This Statistics Show that There Are Ways to be
More Effective and Efficient in New Drug
Discoveries.
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Evidence of “Theory” Leads to “Efficiency”
— based on a case and statistics of T.C. Chou
• Publication: 283 Articles
• Total Citation: > 11,011 Times (as of 04/03/2008)
• 31 Papers Cited Over 100 Times, 12 of them are      
theoretical papers
• Invention: 25 U.S. Patents (> 99th percentile of Inventors)
 With a small number of staff and a moderate budget. It can  be done.  
 The “Theory” and “Approach” play an important Role.
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The Integration of Systems Biology
Concept  Principle Philosophy
The Mighty Mass-Action Law
The Power of Mathematical Induction and Deduction
The Unified Theory & GPS Concept
The Common Link
Deduction Lead to Discovery
The Kinetics and Dynamics
Connecting Entity, Time, Space, Order and Vector
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• The Unified Theory of Dose and Effect
(Chou T.C. J. Theor. Biol. 59: 253-276, 1976)
Merging the Mass-Action Law Principle with Mathematical Induction-Deduction
• The Combination Index Theorem
(Chou T.C. & Talalay P. Adv. Enz. Regul. 22: 27-55, 1984)
• The Integration & Consolidation and Overview
(Chou T.C. Pharmacol. Rev. 58: 621-681, 2006)
[Based on the Thompson-ISI Web of Science search, the above theory, equation, 
method and computer software have been cited in over 3,365 scientific papers in 
over 346 different biomedical journals]
The Mass-Action Law Based New Bio-Informatics
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HYPERBOLIC (FIRST ORDER OR MICHAELIS-MENTEN),      
m = 1,  SIGMOIDAL (HIGHER ORDER), m>1
FOR BOTH CASES:
fa D m
fu Dm
• fa = fraction of system affected, e.g. fractional inhibition
• fu = (1-fa) = fraction unaffected
• D = dose required to produce fa
• Dm = dose required to produce median effect. i.e. ED50, IC50
• m = sigmoidicity (shape)
The Median-Effect Plot (Chou Plot)
Log (fa/fu) = m Log D - m Log Dm;  (y=ax + b)
Median Effect Equation
(T.C. Chou)
=
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The Unified Theory
Derivation of Major Biochemical and Biophysical Equations from the Median-Effect Equation
fa
fu
=(  )DDm
m
The Median-Effect Equation
Chou, J. Theor. Biol. 59: 253-276, 1976
fa /(1–fa ) = (D/Dm)m
log [( fa/(1–fa)] = m[log(D) – logDm]
log [( fa)–1–1]–1 = m log(D) – m logDm
fa/fu = D/Dm
Michaelis-Menten equation
v/Vmax = [1+(Km/S)]–1
Hill equation
log [v/(Vmax –v)] = n log(S) – log (K)
Scatchard equation
[L]b = n[M]t – [L]b 
[L]f Kd Kd
fa = [1+(Dm/D)m ]–1
Henderson-Hasselbalch equation
log [H+] = log Ka  + log 
[HA]
[A–]
pH = pKa + log 
[A–]
[HA]
[Chou T.C. Pharmacol. Rev. 58: 621-681, 2006]
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[Chou T.C. J. Theor. Biol. 59: 253-276, 1976]
a b
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CompuSyn
For Drug Combinations
A Computer Program for Quantitation of 
Synergism and Antagonism in Drug Combinations, 
and the Determination of IC50 and ED50 Values.
By Ting-Chao Chou and Nick Martin
Published and Distributed by
ComboSyn, Inc.
2006
©Copyright 2004
Email: CompuSyn@gmail.com
Fax: 201-857-2608
http://www.combosyn.com
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m = 1, 3, 5; Dm = 1 m = 1; Dm = 0.5, 1, 2, 4, 6, 8, 16
The Dose-Effect Curve:
The Median-Effect Plot:
The Computer Simulation of the Median-Effect Equation
The Revelation of A Fundamental New Concept:
• Dose-Effect Curves Follow the Median-Effect Principle of the Mass-Action Law
• The “GPS” Concept: The “Median” Serves As “The Universal Reference Point”
“One can draw a specific curve with only two data points   --- If they are determined accurately”
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Synergism is more than Additive Effect
Antagonism
What is “Additive Effect”?
is less than Additive Effect
Combination of Multi-Entities
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COMBINED EFFECTS OF TWO DRUGS: D1 AND D2
(Chou & Talalay : Eur. J. Biochem. 115. 207-216, 1981)
CASE 1: FIRST ORDER
(fa)1,2 (fa)1                          (fa)2                            (D)1                         (D)2
(fu)1,2                       (fu)1                     (fu)2                           (Dm)1                     (Dm)2
CASE 2: HIGHER ORDER
(fa)1,2 (fa)1                                           (fa)2
(fu)1,2                                      (fu)1                     (fu)2
(D)1                             (D)2
(Dm)1                          (Dm)2
= = ++
+=
= +
1/m 1/m 1/m
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Algorithm for Computerized Simulation of Synergism, 
Additivism and Antagonism of the Effect of Multiple Drugs
The Median Effect Equation
(1)  fa/fu = (D/Dm)m
(2)  Log( fa/fu) = mlog(D) – mlog(Dm)
(3)  fa = 1/[1+(Dm/D)m]
(4) Dx = Dm[fa /(1–fa )]1/m
(Dx)1,2 = (D)1+ (D)2
and (D)1/(D)2 = P/Q
D = Dose
fa = fraction affected
fu = fraction unaffected
Dm = median-effect dose
m = slope, Hill-type coefficient
or kinetic order
(5) CI = (D)1 + (D)2   = 1   + 1   
(Dx)1     (Dx)2      (DRI)1    (DRI)2
CI : Combination Index
CI = 1 (summation)
< 1 (synergism)
> 1 (antagonism)
DRI: Dose-Reduction Index
(DRI)1 =
(Dx)1 , (DRI)
2
= (Dx)2
(D)1                               (D)2
For n Drug Combinations:
CI =  Σ (D)j(Dx)jnJ=1
(D)1 = (Dx)1,2 x P/(P+Q) 
(D)2 = (Dx)1,2 x Q/(P+Q)
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The Scientist
August 2007 (vol. 21, No. 8, p.15)    
www.the-scientist.com
It is difficult to believe that biomedical communities are still debating how to define an “additive 
drug effect” for over 100 years, even for the combination of only two drugs in vitro. This is after 
spending a tremendous amount of effort and resources during the past decades on basic 
biomedical research. I believe the time has finally come to call for a consensus on “what is an 
additive effect” and thus, on “what is synergy,” to avoid the harms of faulty synergy claims.
Without using a clear definition of synergism, it’s misleading to make claims about synergy, 
whether in paper in a scientific journal, a research grant application, claiming a discovery of a 
new utility patent for a new drug combination, or seeking approval of a new drug combination for 
clinical trials and use from the FDA. Individuals have their own definition of synergism based on 
their preferences, purposes and agenda.
In my recent article on drug combiation,1 I argue that there is only one definition for synergy
(i.e., CI < 1), and there is only one basis to determine it, which is the mass-action law. I extend an 
open invitation to all methods that claim to determine synergism using anything other than the 
combination index method based on the mass-action law.
Ting-Chao Chou
Memorial Sloan-Kettering Cancer Center
New York, NY
chout@mskcc.org
1. T.C. Chou, “Theoretical basis, experimental design, and computerized   
simulation of synergism and antagonism in drug combination studies,”
Pharmacol Rev, 58: 621-81, 2006
What is Synergy?
(Web link: http://pharmrev.aspetjournals.org/cgi/content/abstract/58/3/621) 
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(Chou-Talalay Plot)
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(Chou-Chou Plot)
(Chou-Martin Plot)
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Two Drug Combinations for Seven Anti-HIV Agents and the 
Heptagonal Polygonograms for Cocktail Selection
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Computerized Simulation of 
Synergism/Antagonism
Primary Questions:
 Are there any synergism?
 How much synergism?
 Synergism at what dose levels?
 Synergism at what effect levels? 
 What the exhibited isobologram looks like?
 How many folds dose reduction for each drug 
as results of synergism?
Other Questions:
 Optimal combination ratio
 Schedule dependency
 Selectivity of synergism
 Condition directed synergism
[The Practical & Quantitative Bio-Informatics]
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Toward the “Unified Biology”
—The Mass-Action Law Based Bio-Informatics
• Universal: Regardless of Entities, Mechanisms, Modes of Action
• Dimensionless: Any Units (e.g., µM, µg/ml, IU, Rad…..)
• Simplicity: Effectiveness and Economy
• Serving Humanity: Drug Discovery: single & multi-entities
Risk Assessment
Regulatory Affairs
Conservation of Laboratory Animals
The Unified Theory:  The Median-Effect Principle
The Combination Index Theorem:  “Median” as the Common Link
[Chou. J. Theor. Biol. 39: 253-276, 1976]
[Chou. Pharmacol. Rev. 58: 621-681, 2006]
[From Molecular, Cell, In vitro, In vivo to Epidemiology]
[Draw a curve for Two Data Points: A “GPS” Concept]
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The “Unified Theory” Based on The Mass-Action Law Reveals:
“We can draw a specific curve with only two data points,
if they are determined accurately”
• This small skill (GPS Concept) makes fundamental conceptual
claim that has far reaching consequences in bio-medical sciences
• These consequences include conservation of research time, effort,
and resources, as well as regulatory affairs and saving animal’s 
lives
• We need quantitative biology based on The Mass-Action Law
“Empirical Curve-Fitting” Has No Science in It,  and “Over Stressing 
Statistics” is wasteful and inefficient
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The Mathematical / Philosophical Contents
The Median-Effect Equation
― For details, see Chou T.C. Pharmacol. Rev. 58: 621-681, 2006
The Combination Index Theorem
fa/fu = (D/Dm)m (Eq. 1) log (fa/fu) = m log(D) – m log(Dm)    (Eq. 2)
D = Dm [fa/(1-fa)]1/m (Eq. 3) fa = 1/[1 + (Dm/D)m]     (Eq. 4)
(fa)1,2       (fa)1 (fa)2 (D)1 (D)2 (Eq. 5)
(fu)1,2 (fu)1 (fu)2 (Dm)1              (Dm)2
+= = +
(fa)1,2       (fa)1 (fa)2 (D)1 (D)2 (Eq. 6)
(fu)1,2 (fu)1 (fu)2 (Dm)1              (Dm)2
+= = +
1/m 1/m 1/m
(D)j
(Eq. 7)(Dx)j
n
(CI)x
n
= Σ
j = 1
(D)1       (D)2 (D)1 (D)2 (Eq. 8)
(Dx)1 (Dx)2 (Dm)1 [fa/(1-fa)] (Dm)2 [fa/(1-fa)]
+ +=
1/m1 1/m2
=CI
Common Link
Generalization
Integration
D & fa
Interchange
Kinetic Order
Entities
Substance & Function
N = 1~ n
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The Modern Science Algorithms 
and The Ancient Philosophy
• New Mathematical  Interpretations of Ancient Philosophy
[Confucian Doctrine of the Mean (中庸); Dao’s Harmony (和諧/中節); 
Fu-Si Ba Gua (伏羲八卦) and Chou’s Wu-ji er Tai-ji (無極而太極)]
• Common Link among Theories and Philosophy
[The Median-Effect Principle of the Mass-Action Law]
(質量作用中效定理)
• Introduce the Dynamic Equilibral Philosophy for 
Interchangeability of “Dose and Effect”;
“Material and Mind”; “Yin and Guo”; 
and “Knowledge and Execution”
• Complements of East and West Philosophy via Scientific Exploration
[Western Science and Eastern Principle] 
(中學為體,西學為用)
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Ancient Philosophy and Modern Interpretations
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Pure-Noncompetitive Harmony
2  Kis Kii
Kis + Kii
IC50 = (Eq. 9) Harmonic Mean
Rate Equation for Non-competitive Inhibition:
vi = VSKm [ 1 + (I/Kis) ] + S [ 1 + (I/Kii) ]
Graphics for Non-competitive Inhibition:
vi
1 = (1   +           )Km 
V
I
Kis
1
S
+ (1   +           )1
V
I
Kii
Median
Rearrangement of Eq. 10 yields:
Chou, T.C. Mol. Pharmacol. 
10: 235-247, 1974
(slope) (intercept)
N
a
t
u
r
e
 
P
r
e
c
e
d
i
n
g
s
 
:
 
d
o
i
:
1
0
.
1
0
3
8
/
n
p
r
e
.
2
0
0
8
.
2
0
6
4
.
1
 
:
 
P
o
s
t
e
d
 
1
0
 
J
u
l
 
2
0
0
8
41
Therefore, a plot (i.e., the Lineweaver-Burk plot) of x = 1/S vs. y = 1/vi
yields a  slope of :
[ (slope)i /  (slope)o ] – 1
Kis =
I
Kii =
I
[ (y-intercept)i /  (y-intercept)o ] – 1
(1   +           )Km 
V
I
Kis
1
V
I
Kii
(1   +           )and a y-intercept of
: 
Hence,
When the plots of the uninhibited control and the noncompetitive inhibitor intercept both on the x-
axis on the same point, then Kis = Kii which leads to IC50 = Ki, and, therefore, “pure non-
competition” is ensured for harmony. 
Therefore, there is a physical, chemical, geometrical, mathematical and ethical link between 
“harmony” and “non-competitiveness”, and literally, Chung-Yung is the “center of harmony”
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Modern Topological Analysis The Corresponding 
Fu-Si Ba Gua(Chou, TC. Pharmacol. Rev. 58: 621-681, 2006)
伏羲八卦(> 2000 BC)
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Applications of MEP and Combination Index Theorem
 Simplified, Efficient, Economical Small Size Experimentation
 Non-Empirical Curve-Fitting for Dose-Effect Curves
 Calculation of Ki from IC50
 Determination of Mass-Action Law Parameters
 Mass-Action Law Based Algorithms for Computer Simulation
 Definition for the Additive Effect or Definition of Synergism
 Low Dose-Risk for Carcinogens, Toxic Substances or Radiation
 Epidemiological Projection of Age-Specific Cancer or Other 
Disease Rates
 Conservation of Laboratory Animals
 Design of Anti-HIV Cocktail, or Combination Chemotherapy 
of Cancer by Using Polygonogram
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Merging the Mass-Action Law with Mathematical Induction and Deduction 
Leads to the Unified Theory:
(Chou, T.C. J. Theoretical Biol. 59: 253-276, 1976)
The Median-Effect Principle (MEP)
The Median-Effect Equation (MEE)
A. The “Median” is the “Common Link” for
• The 1st order to the Higher-Order Dynamics
• The Single Entity and Multiple Entities
• Competitiveness
• Exclusivity
B. The “Median” is the “Universal Reference Point” for
• The GPS Concept for Bio-Informatics
• Drawing a Specific Curve for Only Two Data Points
• Using the Data to fit the Mass-Action Law
C. These “Common Link” and the “Reference Point” are also Revealed 
by the Confucian Doctrine of the Mean; Chou Dun-Yi’s Wu-Ji Er    
Tai-Ji; Dao’s Five Elements and Harmony; and Fu-Si’s Ba-Gua.
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Merging the Mass-Action Law with Mathematical Induction and Deduction 
Leads to the Multiple Drug Effect Equation: 
(Chou-Talalay, Eur. J. Biochem. 115: 207-216, 1981)
The Combination Index Theorem
The Isobologram Equation
The Dose-Reduction Equation
• General, Efficient, Economical, Dimensionless and Mechanism 
Independent
• Algorithms for Computer Simulation of  Synergism
• Define Synergism (CI < 1), Additive Effect (CI = 0), and Antagonism    
(CI > 1)
• Use Any Units: µM, ng/ml, IU, MOI, Rad, etc.
• Dose-Reduction Index
• The Fa-CI Plot (Chou-Talalay Plot); Normalized Isobologram (Chou-
Chou Plot); Fa-DRI Plot (Chou-Martin Plot), and Polygonogram by 
Computer Automation
• “Part” and “Whole” Equation for Ki/IC50
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New Concept for New Biology
Are We Lopsided? How is the Peer Review Today?
--- Are New Ideas Encouraged or Suppressed?
Contrast of New and Old
1. Mass-Action Law vs. Empirical
2. Convergent vs. Divergent
3. Quantitative vs. Qualitative
4. Deterministic vs. Statistical
5. GPS vs. Random Walk
6. Economic vs. Consumptionism
7. Fundamental vs. Mechanistics
8. Biological System vs. System Biology
9. Definition vs. Semantics
10. Novelty vs. Conformationism
Issues
Draw a Dose-Effect Curve?
Philosophy?
What is Additive?
What is Synergy?
Universal Reference Point?
Efficiency?
Unified Theory?
Integration?
Algorithm?
Peers?
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